Approval · Notice of Compliance 9807 · 2008
APRI 21: Notice of Compliance 9807
Issued September 29, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9807
- Date
- September 29, 2008
- Company
- Barr Laboratories IncPomona, New York, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Oral contraceptive
- Canadian reference product
- MARVELON (Organon Canada Inc.)
Products in this notice
Medicinal ingredients
- DESOGESTREL 0.15 MG per TAB
- ETHINYL ESTRADIOL 0.03 MG per TAB